Ann Lab Med.  2017 Nov;37(6):550-552. 10.3343/alm.2017.37.6.550.

Lipoprotein X Detected in a Case of Hypercholesterolemia Associated With Chronic Cholangiohepatitis

• Ha J
• Lee SG
• Kim JH

• KMID: 2426001
• DOI: http://doi.org/10.3343/alm.2017.37.6.550

Abstract

No abstract available.

MeSH Terms

Hypercholesterolemia*
Lipoprotein-X*
Lipoproteins*
Lipoprotein-X
Lipoproteins

Figure

• 

  Fig. 1 Lipoprotein electrophoresis. (A) Sample with normal lipid profiles, (B) patient sample at admission (hyperbilirubinemia), and (C) patient sample after five months (improvement).

• 

  Fig. 2 LDL sub-fraction electrophoresis (Lipoprint LDL System; Quantimetrix, Redondo Beach, CA, USA) showing an additional large, abnormal HDL sub-fraction (red circle).Abbreviations: VLDL, very low density lipoprotein; MID, midband.

Reference

1. Manzato E, Fellin R, Baggio G, Walch S, Neubeck W, Seidel D. Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest. 1976; 57:1248–1260. PMID: 816809.

2. Seidel D, Gjone E, Blomhoff JP, Geisen HP. Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency--studies on the apolipoprotein composition of isolated fractions with identification of LP-X. Horm Metab Res. 1974; (Suppl 4):6–11. PMID: 4371225.

3. Fellin R, Manzato E, Zotti S, Baggio G, Briani G, Rugge M. Lipoprotein-X and diagnosis of cholestasis: comparison with other biochemical parameters and liver biopsy. Clin Chim Acta. 1978; 85:41–47. PMID: 25728.

4. Fischer M, Falkensammer C, Barouch G, Wuketich S, Kromberger O, Schnack H. The diagnosis of cholestasis: lipoprotein X (LP-X) (author's transl). Wien Klin Wochenschr. 1975; 87:524–531. PMID: 5812.

5. Milewski B, Palynyczko Z. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases. Pol Med Sci Hist Bull. 1975; 15:551–555. PMID: 1228704.

6. Liersch M, Baggio G, Heuck CC, Seidel . Effect of lipoprotein-X on hepatic cholesterol synthesis. Atherosclerosis. 1977; 26:505–514. PMID: 193523.

7. Peynet J, Fénéant-Thibault M, Legrand A, Marot D, Rousselet F, Lemonnier A. Isolation and characterization of an abnormal alpha slow-moving high-density lipoprotein subfraction in serum from children with longstanding cholestasis. Clin Chem. 1986; 32:646–651. PMID: 3955813.

8. Miyahara K, Kasahara N, Kondo Y, Imai Y, Matuzaki F. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med. 1991; 30:354–359. PMID: 1942649.

9. Kim S, Chun S, Lee W, Kim GS, Min WK. Cholestasis causes discrepancy in HDL-cholesterol levels measured using various methods. Lab Med Online. 2012; 2:174–178.

10. Sivakumar T, Chaidarun S, Lee HK, Cervinski M, Comi R. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer. J Clin Lipidol. 2011; 5:324–328. PMID: 21784379.